JapanStake
Chemicals · Fiscal year end Sep 30

Waqoo Inc.

4937

株式会社Waqoo

FIGI BBG00R2818R24937.T4937 JPCorp. no. 9010901023800

Latest half-year results

First half · fiscal year to 2026-09 · filed 2026-05-14

For the first half of the fiscal year to 2026-09: Revenue ¥1.1 billion (+35.8% YoY), Ordinary income ¥0.1 billion, Net income ¥0.1 billion.

This periodYear on year
Revenue¥1.1bn+35.8%
Ordinary profit¥135m—
Net profit to owners¥136m—

From the securities report on EDINET, which states no forecast. History via /v1/companies/4937/earnings-releases.

Financials

Japan GAAP · consolidated · fiscal year to 2025-09-30
Revenue
¥2.0bn
Net income
¥44m
ROE
2.1%
Equity ratio
65.1%
Dividend / share
—
Employees
93
Revenue · ¥bn
FY2022: ¥2.7bn 2.73 FY2022FY2023: ¥1.7bn 1.73 FY2023FY2024: ¥1.9bn 1.94 FY2024FY2025: ¥2.0bn 1.96 FY2025
Net income · ¥m
FY2022: −¥57m -57.2 FY2022FY2023: ¥28m 28.4 FY2023FY2024: −¥17m -17.4 FY2024FY2025: ¥44m 44.1 FY2025
Fiscal yearRevenueNet incomeTotal assetsNet assetsROEEPSOperating CF
2025-09-30¥1,961m¥44m¥3,199m¥2,092m2.1%¥12.32¥136m
2024-09-30¥1,943m−¥17m¥3,134m¥2,140m—¥-5.03¥49m
2023-09-30¥1,726m¥28m¥1,581m¥773m3.7%¥9.43¥456m
2022-09-30¥2,731m−¥57m¥1,563m¥743m—¥-19.04¥169m

Indicators

Computed by us from filings · fiscal year to 2025-09-30
MetricValuePercentile among listed companies
ROE, %2.111.3
Ordinary margin0.077755.6
Equity ratio, %65.166.2
Revenue growth0.00929.2
Net income growth3.533296.4
Operating cash flow / assets0.042635.4
Policy-uncertainty measure1.05 Share of the report's text discussing policy-related uncertainty, by policy area. Proprietary text method.
Trade & tariffs 2
Ownership activity 0 filer(s) stated they may make proposals in 365 days; 0 new 5% holder(s) in 180 days; net stake change 0.00pt in 90 days; 0.0% held by other listed companies.

Results wording balance: +0.60. Proprietary text method; it describes the wording only and does not interpret context.

Interest example: if all ¥731m of reported debt repriced by 50 basis points, a year's interest would rise by ¥4m, 2.7% of operating cash flow. Our arithmetic only, not a forecast: fixed-rate debt and hedges are ignored.

Via /v1/companies/4937/indicators. Descriptive figures, not a rating and not investment advice.

From other filings

As the company states them
Internal control, 2025-12-23: see filing 上記の評価の結果、当連結会計年度末日時点において、当社グループの財務報告に係る内部統制は有効であると判断いたしました。 Filing

Segments, votes and tender offers

Stated in EDINET filings
Segments: Direct to Consumer Business, Medical Support. /v1/companies/4937/segments
Latest voting result: 2025-12-23 · 定款一部変更の件 · passed. /v1/companies/4937/voting
Latest tender-offer filing: 2025-12-15 · result · 株式会社Waqoo. /v1/companies/4937/tender-offers

Ownership changes

All companies →

Trades by 5% holders

From the 60-day trade tables in 5% reports
¥649¥1,474¥2,299 2022-06-172025-12-19 2025-12-19 · sold 989,802 @ ¥1,445 · individual filer2025-12-12 · bought 575,052 @ ¥1,900 · SBCメディカルグループ株式会社2025-12-12 · sold 40,500 @ ¥1,900 · individual filer2025-12-12 · sold 40,500 @ ¥1,900 · individual filer2025-11-13 · bought 989,802 @ ¥1,445 · SBCメディカルグループ株式会社2025-06-23 · sold 37,000 @ ¥902 · individual filer2025-06-23 · sold 37,000 @ ¥902 · individual filer2025-06-10 · sold 180,500 @ ¥1,052 · 株式会社BPMH2024-01-04 · bought 190,400 @ ¥2,299 · パーシング株式会社2022-06-17 · sold 181,958 @ ¥649 · individual filer2022-06-17 · sold 779,844 @ ¥649 · individual filer2022-06-17 · bought 989,802 @ ¥649 · individual filer
Bought SoldHover a dot for the trade
HolderPeriodNet sharesNet % of sharesAvg. filed priceRange
individual filer2025-12-19 – 2025-12-19-989,802−27.25pt¥1,445¥1,445–1,445
individual filer2022-06-17 – 2025-12-12-259,458−8.19pt¥880.35¥649–1,900
individual filer2022-06-17 – 2025-12-12-857,344−28.12pt¥719.01¥649–1,900
SBCメディカルグループ株式会社2024-01-04 – 2025-12-12+1,564,854+43.15pt¥1,612.2¥1,445–1,900
株式会社BPMH2024-12-10 – 2025-06-1000.00pt¥1,052¥1,052–1,052
パーシング株式会社2024-01-04 – 2024-01-04+190,400+5.28pt¥2,299¥2,299–2,299
individual filer2022-06-17 – 2022-06-17+989,802+32.98pt¥649¥649–649
ニッセイ・キャピタル株式会社2022-01-25 – 2022-01-28-1,600−0.05pt——

Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/4937/trades.

5% filings

Large shareholding reports on 4937
FiledFilerStakeChangeStated purpose
2026-04-28individual filer37.22%+4.32pt—
2026-04-27individual filer37.22%+4.32pt—
2025-12-25SBC Medical Group Co., Ltd.52.81%0.00pt—
2025-12-19individual filer15.02%−2.30pt—
2025-12-19SBC Medical Group Co., Ltd.52.81%+15.73pt—
2025-12-19individual filer15.03%−2.29pt—
2025-11-25SBC Medical Group Co., Ltd.37.08%−0.14pt—
2025-11-21SBC Medical Group Co., Ltd.37.08%−0.14pt—
2025-11-20SBC Medical Group Co., Ltd.37.08%−0.14pt—
2025-06-30individual filer17.32%−2.05pt—

Major shareholders

As of fiscal year end 2025-09-30
ShareholderSharesRatio
individual holder989,80228.09%
individual holder386,50210.97%
SBCメディカルグループ株式会社353,60010.03%
株式会社M&M240,4566.82%
株式会社MC180,5005.12%
individual holder111,2003.15%
individual holder74,0002.10%
株式会社日本カストディ銀行(信託口)69,8001.98%
日本マスタートラスト信託銀行株式会社(信託口)56,3001.59%
individual holder54,4001.54%

Get this as JSON

GET /v1/companies/4937
GET /v1/companies/4937/financials
GET /v1/companies/4937/details
GET /v1/companies/4937/segments
GET /v1/companies/4937/voting
GET /v1/companies/4937/tender-offers
GET /v1/companies/4937/indicators
GET /v1/companies/4937/earnings-releases
GET /v1/events?ticker=4937
GET /v1/companies/4937/trades         
GET /v1/companies/4937/cross-holdings 
GET /v1/companies/4937/brief          

Plans from $9 a month · Documentation